Login / Signup

SDS22 coordinates the assembly of holoenzymes from nascent protein phosphatase-1.

Xinyu CaoMadryn LakeGerd Van der HoevenZander ClaesJavier Del Pino GarcíaSarah LemaireElora C GreinerSpyridoula KaramanouAleyde Van EyndeArminja N KettenbachDaniel Natera-de BenitoLaura Carrera-GarcíaCristina Hernando DavalilloCarlos OrtezAndres NascimentoRoser UrreiztiMathieu Bollen
Published in: Nature communications (2024)
SDS22 forms an inactive complex with nascent protein phosphatase PP1 and Inhibitor-3. SDS22:PP1:Inhibitor-3 is a substrate for the ATPase p97/VCP, which liberates PP1 for binding to canonical regulatory subunits. The exact role of SDS22 in PP1-holoenzyme assembly remains elusive. Here, we show that SDS22 stabilizes nascent PP1. In the absence of SDS22, PP1 is gradually lost, resulting in substrate hyperphosphorylation and a proliferation arrest. Similarly, we identify a female individual with a severe neurodevelopmental disorder bearing an unstable SDS22 mutant, associated with decreased PP1 levels. We furthermore find that SDS22 directly binds to Inhibitor-3 and that this is essential for the stable assembly of SDS22:PP1: Inhibitor-3, the recruitment of p97/VCP, and the extraction of SDS22 during holoenzyme assembly. SDS22 with a disabled Inhibitor-3 binding site co-transfers with PP1 to canonical regulatory subunits, thereby forming non-functional holoenzymes. Our data show that SDS22, through simultaneous interaction with PP1 and Inhibitor-3, integrates the major steps of PP1 holoenzyme assembly.
Keyphrases
  • transcription factor
  • signaling pathway
  • electronic health record
  • drug induced
  • big data